| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.HFC.2011.06.008 |
| P953 | full work available online at | https://api.elsevier.com/content/article/PII:S1551713611000602?httpAccept=text/plain |
| https://api.elsevier.com/content/article/PII:S1551713611000602?httpAccept=text/xml | ||
| P698 | PubMed publication ID | 21925434 |
| P2093 | author name string | Luca Bettari | |
| Salvador Borges-Neto | |||
| P2860 | cites work | Prognostic value of a Doppler index combining systolic and diastolic performance in idiopathic-dilated cardiomyopathy | Q50857204 |
| Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy | Q51102867 | ||
| Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality | Q51939011 | ||
| Relation of mean right atrial pressure to echocardiographic and Doppler parameters of right atrial and right ventricular function | Q52308146 | ||
| Impact of Viability, Ischemia, Scar Tissue, and Revascularization on Outcome After Aborted Sudden Death | Q53640971 | ||
| Use of the living with heart failure questionnaire to ascertain patients' perspectives on improvement in quality of life versus risk of drug-induced death | Q53642395 | ||
| Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril | Q54035462 | ||
| Persistence of Restrictive Left Ventricular Filling Pattern in Dilated Cardiomyopathy: An Ominous Prognostic Sign | Q62717273 | ||
| Left ventricular hypertrophy is associated with worse survival independent of ventricular function and number of coronary arteries severely narrowed | Q68410736 | ||
| Mitral annular descent velocity by tissue Doppler echocardiography as an index of global left ventricular function | Q71112042 | ||
| Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction. Results of the SOLVD echocardiography substudy | Q72220327 | ||
| Role of surrogate end points in the evaluation of drugs for heart failure | Q72932833 | ||
| Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group | Q73270985 | ||
| Antiremodeling effects on the left ventricle during beta-blockade with metoprolol in the treatment of chronic heart failure | Q73321605 | ||
| Predictive value of systolic and diastolic function for incident congestive heart failure in the elderly: the cardiovascular health study | Q73661222 | ||
| Echocardiographic predictors of clinical outcome in patients with left ventricular dysfunction enrolled in the SOLVD registry and trials: significance of left ventricular hypertrophy. Studies of Left Ventricular Dysfunction | Q73662518 | ||
| Impact of blunted pulmonary venous flow on the outcome of patients with left ventricular systolic dysfunction secondary to either ischemic or idiopathic dilated cardiomyopathy | Q73901516 | ||
| Prognostic Significance of Microvascular Obstruction by Magnetic Resonance Imaging in Patients With Acute Myocardial Infarction | Q74302899 | ||
| Surrogate end points in heart failure | Q78032634 | ||
| Right ventricular dysfunction assessed by cardiovascular magnetic resonance imaging predicts poor prognosis late after myocardial infarction | Q79827049 | ||
| Usefulness of tissue doppler and color M-mode indexes of left ventricular diastolic function in predicting outcomes in systolic left ventricular heart failure (from the ADEPT study) | Q80375677 | ||
| Usefulness of left atrial volume in predicting first congestive heart failure in patients > or = 65 years of age with well-preserved left ventricular systolic function | Q81230089 | ||
| Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease | Q83929856 | ||
| Single-photon emission computed tomography myocardial perfusion defects are associated with an increased risk of all-cause death, cardiovascular death, and sudden cardiac death | Q84647740 | ||
| Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee | Q22306347 | ||
| Biomarkers and surrogate endpoints: preferred definitions and conceptual framework | Q28203935 | ||
| 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults | Q28239484 | ||
| Biomarkers in heart failure | Q28280109 | ||
| Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group | Q33157410 | ||
| Independent relationship of left atrial size and mortality in patients with heart failure: an individual patient meta-analysis of longitudinal data (MeRGE Heart Failure) | Q33507493 | ||
| A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure | Q34106793 | ||
| Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy | Q34147980 | ||
| Use of biomarkers and surrogate endpoints in drug development and regulatory decision making: criteria, validation, strategies | Q34192717 | ||
| A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. Vesnarinone Trial Investigators | Q34483643 | ||
| Cardiovascular death and left ventricular remodeling two years after myocardial infarction: baseline predictors and impact of long-term use of captopril: information from the Survival and Ventricular Enlargement (SAVE) trial | Q34743807 | ||
| ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology | Q34830023 | ||
| Left ventricular long axis function in diastolic heart failure is reduced in both diastole and systole: time for a redefinition? | Q35579634 | ||
| Prognosis in diastolic heart failure | Q36186625 | ||
| Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction | Q36741315 | ||
| Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy | Q36761955 | ||
| I-123-mIBG myocardial imaging for assessment of risk for a major cardiac event in heart failure patients: insights from a retrospective European multicenter study | Q37017184 | ||
| End points for clinical trials in acute heart failure syndromes | Q37516738 | ||
| Clinical trials of pharmacological therapies in acute heart failure syndromes: lessons learned and directions forward | Q37710255 | ||
| Infarct morphology identifies patients with substrate for sustained ventricular tachycardia | Q38416250 | ||
| Impact of sympathetic innervation on recurrent life-threatening arrhythmias in the follow-up of patients with idiopathic ventricular fibrillation | Q40334389 | ||
| Incremental prognostic power of single-photon emission computed tomographic myocardial perfusion imaging in patients with known or suspected coronary artery disease. | Q40455447 | ||
| Left ventricular hypertrophy and geometric remodeling in hypertension: stimuli, functional consequences and prognostic implications | Q40538426 | ||
| Surrogate endpoints in clinical trials: definition and operational criteria | Q41310696 | ||
| Effects of low-dose oral enoximone administration on mortality, morbidity, and exercise capacity in patients with advanced heart failure: the randomized, double-blind, placebo-controlled, parallel group ESSENTIAL trials | Q41859441 | ||
| Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study | Q43147933 | ||
| Impact of right ventricular involvement on mortality and morbidity in patients with inferior myocardial infarction | Q43518242 | ||
| Prognostic role of myocardial blood flow impairment in idiopathic left ventricular dysfunction | Q43854302 | ||
| Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis | Q43939852 | ||
| Comparison of the prognostic value of cardiac iodine-123 metaiodobenzylguanidine imaging and heart rate variability in patients with chronic heart failure: a prospective study | Q44283422 | ||
| Prognostic implications of an initial loss of cardiac metaiodobenzylguanidine uptake and diabetes mellitus in patients with left ventricular dysfunction | Q44443677 | ||
| Myocardial perfusion reserve and peripheral endothelial function in patients with idiopathic dilated cardiomyopathy | Q44707489 | ||
| Effects of carvedilol on left ventricular remodeling after acute myocardial infarction: the CAPRICORN Echo Substudy | Q44714930 | ||
| Comparative accuracy of B-type natriuretic peptide and tissue Doppler echocardiography in the diagnosis of congestive heart failure | Q47695817 | ||
| Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators | Q48118604 | ||
| Tei index and neurohormonal activation in patients with incident heart failure: serial changes and prognostic value. | Q48654932 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | heart failure | Q181754 |
| P304 | page(s) | 509-518 | |
| P577 | publication date | 2011-10-01 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Heart failure clinics | Q26853797 |
| P1476 | title | Imaging surrogate end points in heart failure trials | |
| Imaging Surrogate End Points in Heart Failure Trials | |||
| P478 | volume | 7 |
| Q36175645 | The relationship of left ventricular trabeculation to ventricular function and structure over a 9.5-year follow-up: the MESA study | cites work | P2860 |
Search more.